Biotechnology company CytoDyn told investors on April 13 that five patients with mild-to-moderate COVID-19 symptoms were able to get off oxygen after taking its leronlimab drug, Proactive Investors reports.
Spinal Tech
Johnson & Johnson reported a 7.5 percent drop in orthopedic sales during the first quarter of 2020, disrupted by the coronavirus.
Medicrea reported its full-year 2019 and first-quarter 2020 financial results, posting a $17 million (15.6 million euro) loss on the year.
Biotechnology company CytoDyn appointed Scott Kelly, MD, as CMO and head of business development on April 13.
A Barclays analyst cut her rating on Stryker amid the COVID-19 pandemic.
Advertisement
Orthopedic fixation company Ossio recently added former Johnson & Johnson executive Gary Pruden to its board of directors, Biospace reports.
Zimmer Biomet plans to drastically scale back operations for two weeks due to the COVID-19 pandemic, WANE 15 reports.
The global cervical total disc replacement devices market is expected to surpass $5.3 billion by 2027, demonstrating a compound annual growth rate of 21.7 percent, according to Coherent Market Insights.
Orthofix is temporarily reducing the salaries of its U.S. employees, with the largest cuts being implemented at the executive and board level.
Alphatec Holdings reported its first quarter revenue grew 25 percent to 26 percent based on its preliminary results, but the coronavirus has forced the company to make some changes.